-
Role of endoscopy in gastroesophageal reflux disease
-
Daniel Martin Simadibrata, Elvira Lesmana, Ronnie Fass
-
Clin Endosc 2023;56(6):681-692. Published online October 12, 2023
-
DOI: https://doi.org/10.5946/ce.2023.182
-
-
Abstract
PDF PubReader ePub
- In general, gastroesophageal reflux disease (GERD) is diagnosed clinically based on typical symptoms and/or response to proton pump inhibitor treatment. Upper gastrointestinal endoscopy is reserved for patients presenting with alarm symptoms, such as dysphagia, odynophagia, significant weight loss, gastrointestinal bleeding, or anorexia; those who meet the criteria for Barrett’s esophagus screening; those who report a lack or partial response to proton pump inhibitor treatment; and those with prior endoscopic or surgical anti-reflux interventions. Newer endoscopic techniques are primarily used to increase diagnostic yield and provide an alternative to medical or surgical treatment for GERD. The available endoscopic modalities for the diagnosis of GERD include conventional endoscopy with white-light imaging, high-resolution and high-magnification endoscopy, chromoendoscopy, image-enhanced endoscopy (narrow-band imaging, I- SCAN, flexible spectral imaging color enhancement, blue laser imaging, and linked color imaging), and confocal laser endomicroscopy. Endoscopic techniques for treating GERD include esophageal radiofrequency energy delivery/Stretta procedure, transoral incisionless fundoplication, and endoscopic full-thickness plication. Other novel techniques include anti-reflux mucosectomy, peroral endoscopic cardiac constriction, endoscopic submucosal dissection, and endoscopic band ligation. Currently, many of the new endoscopic techniques are not widely available, and their use is limited to centers of excellence.
-
Citations
Citations to this article as recorded by 
- Exploring esophagogastric junction morphology and contractile integral: implications for refractory gastroesophageal reflux disease pathophysiology
Sihui Lin, Zhilong Chen, Wei Jiang, Yucheng Zhu Scandinavian Journal of Gastroenterology.2025; 60(2): 130. CrossRef - Patients Presenting With Reflux Symptoms - Whom to Test and Whom to Treat?
Noy Lapidot Alon, Tomas Navarro Rodriguez, Ronnie Fass The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2025; 25(1): 7. CrossRef - 'Unmasking Endoscopic Patterns in PPI-Refractory GERD: Insights into Findings and Risk Factors'
A Samad Endoscopy.2025; 57(S 02): S335. CrossRef - Potassium-competitive Acid Blockers for Treatment of Extraesophageal Symptoms and Signs
Gwang Ha Kim, Ronnie Fass Journal of Neurogastroenterology and Motility.2025; 31(2): 170. CrossRef - ESÔFAGO DE BARRETT: UMA REVISÃO BIBLIOGRÁFICA
Marcelo Vinícius Pereira Silva, Elaine Timm, Allan Martins De Oliveira, Elizeu Augusto De Freitas Junior , Marlison Caldas Gonçalves Pereira Brazilian Medical Students.2025;[Epub] CrossRef - Long-term efficacy of endoscopic radiofrequency Stretta therapy for patients with refractory gastroesophageal reflux disease
Sung Eun Kim Clinical Endoscopy.2024; 57(1): 48. CrossRef - Correlation of Endoscopic and Histopathological Diagnoses in Upper Gastrointestinal Tract Lesions: A Cross-Sectional Study
Sudhasmita Rauta, Pratima Baisakh, Aswini K Sahoo, Dhiren K Panda, Manas R Baisakh, Sushree s Dash Cureus.2024;[Epub] CrossRef - The role of ghrelin and leptin in the formation of morphological changes esophagus of patients with gastro-esophageal reflux disease against type 2 diabetes
Olha Bondar-Keleberda EUREKA: Health Sciences.2023; (4): 24. CrossRef
-
7,393
View
-
447
Download
-
5
Web of Science
-
8
Crossref
|